The global laparoscopic gynecological procedures market size was valued at USD 20.5 billion in 2025 and is projected to grow from USD 21.2 billion in 2026 to USD 26.1 billion by 2033, at a CAGR of 3.1% from 2026 to 2033. North America dominated the market, accounting for the largest share of 50.2% in 2025.
Laparoscopic gynecological procedures are experiencing growth due to the increasing adoption of minimally invasive surgeries, driven by patient preference for shorter recovery times and reduced scarring; the rising prevalence of gynecological disorders, such as uterine fibroids and endometriosis; and technological advancements, including robotic-assisted surgery.
Moreover, surgical robots are driving innovation in the laparoscopic gynecological procedures industry by enabling enhanced precision, reproducibility, and access in complex pelvic surgeries. Advanced systems such as the da Vinci and Senhance platforms are equipped with wristed instruments, high-definition 3D visualization, and motion scaling, which enable gynecologic surgeons to perform intricate procedures, including endometriosis excision and myomectomy, with enhanced control and minimal invasiveness. For instance, the new study published by Intuitive Surgical in April 2025 highlights that robotic-assisted surgery (RAS) increases access to minimally invasive care, especially in underserved "medical deserts," by overcoming barriers such as limited surgeon training and hospital infrastructure. Hospitals adopting RAS saw higher rates of minimally invasive surgery and expanded access across diverse patient groups, improving patient outcomes. These platforms also accelerate innovation through the integration of digital capabilities, such as real-time analytics, AI-assisted image guidance, and feedback, which collectively improve surgical planning and intraoperative decision-making. Furthermore, the ability of robotic platforms to standardize techniques across varying skill levels is also transforming training and credentialing models, making complex laparoscopic procedures more widely accessible.
The demand for minimally invasive laparoscopic techniques in gynecology is further accelerated by physician training trends and technology integration. Gynecologists are increasingly opting for laparoscopic fellowships and simulation-based training platforms to improve laparoscopic skills, especially for procedures such as total laparoscopic hysterectomy (TLH), laparoscopic supracervical hysterectomy (LSH), and laparoscopic ovarian cystectomy. Market players are responding to this demand with advanced education programs. For instance, in November 2023, Ethicon, a Johnson & Johnson MedTech company, launched an AI-powered laparoscopic skills training platform at the American Association of Gynecological Laparoscopists (AAGL) Global Congress. This platform aims to enhance surgical training by providing surgeons with real-time feedback and objective performance metrics. The AI analyzes surgical techniques, offering personalized guidance to improve skills and accelerate learning. The platform's features include objective assessment of surgical performance, personalized feedback, and opportunities for repeated practice in a simulated environment, ultimately aimed at improving surgical outcomes. This innovation represents a significant advancement in surgical education and training, leveraging AI to optimize the learning process for surgeons. Such initiatives are further enhancing the laparoscopic procedure, offering capabilities of healthcare providers, further increasing the preference towards minimally invasive procedures over traditional open procedures.
The increasing prevalence of gynecological disorders such as endometriosis and uterine fibroids is significantly fueling the demand for laparoscopic interventions. Laparoscopy is increasingly preferred for the diagnosis and treatment of these conditions due to its ability to offer targeted, minimally invasive management with lower postoperative complications and faster recovery compared to open surgery. According to the World Health Organization (WHO), around 10% or approximately 190 million reproductive-age individuals globally are affected by endometriosis. Similarly, a study published in Springer Nature in May 2023 analyzed global trends in uterine fibroids from 1990 to 2019, revealing a 67% increase in incidence, 79% in prevalence, and 77% in years lived with disability. Age-period-cohort modeling indicated rising burdens, especially in low- and middle-Socio-demographic Index regions, with peak incidence at ages 35-44. This rise in gynecological procedures significantly contributesto the rise in demand for advanced laparoscopic procedures.
Moreover, the trend toward early-stage detection of gynecological conditions, driven by increased awareness and access to gynecological care, has expanded the pool of eligible patients for laparoscopic gynecological procedures. This shift is pushing healthcare facilities to invest in laparoscopic systems and training. Manufacturers of laparoscopic instruments and energy devices are capitalizing on this surge by offering disease-specific toolkits, such as fibroid morcellators and endometriosis resection kits, which are increasing procedural efficiency.
Laparoscopic gynecological procedures are experiencing growth due to the increasing adoption of minimally invasive surgeries, driven by patient preference for shorter recovery times and reduced scarring; the rising prevalence of gynecological disorders, such as uterine fibroids and endometriosis; and technological advancements, including robotic-assisted surgery.
Moreover, surgical robots are driving innovation in the laparoscopic gynecological procedures industry by enabling enhanced precision, reproducibility, and access in complex pelvic surgeries. Advanced systems such as the da Vinci and Senhance platforms are equipped with wristed instruments, high-definition 3D visualization, and motion scaling, which enable gynecologic surgeons to perform intricate procedures, including endometriosis excision and myomectomy, with enhanced control and minimal invasiveness. For instance, the new study published by Intuitive Surgical in April 2025 highlights that robotic-assisted surgery (RAS) increases access to minimally invasive care, especially in underserved "medical deserts," by overcoming barriers such as limited surgeon training and hospital infrastructure. Hospitals adopting RAS saw higher rates of minimally invasive surgery and expanded access across diverse patient groups, improving patient outcomes. These platforms also accelerate innovation through the integration of digital capabilities, such as real-time analytics, AI-assisted image guidance, and feedback, which collectively improve surgical planning and intraoperative decision-making. Furthermore, the ability of robotic platforms to standardize techniques across varying skill levels is also transforming training and credentialing models, making complex laparoscopic procedures more widely accessible.
The demand for minimally invasive laparoscopic techniques in gynecology is further accelerated by physician training trends and technology integration. Gynecologists are increasingly opting for laparoscopic fellowships and simulation-based training platforms to improve laparoscopic skills, especially for procedures such as total laparoscopic hysterectomy (TLH), laparoscopic supracervical hysterectomy (LSH), and laparoscopic ovarian cystectomy. Market players are responding to this demand with advanced education programs. For instance, in November 2023, Ethicon, a Johnson & Johnson MedTech company, launched an AI-powered laparoscopic skills training platform at the American Association of Gynecological Laparoscopists (AAGL) Global Congress. This platform aims to enhance surgical training by providing surgeons with real-time feedback and objective performance metrics. The AI analyzes surgical techniques, offering personalized guidance to improve skills and accelerate learning. The platform's features include objective assessment of surgical performance, personalized feedback, and opportunities for repeated practice in a simulated environment, ultimately aimed at improving surgical outcomes. This innovation represents a significant advancement in surgical education and training, leveraging AI to optimize the learning process for surgeons. Such initiatives are further enhancing the laparoscopic procedure, offering capabilities of healthcare providers, further increasing the preference towards minimally invasive procedures over traditional open procedures.
The increasing prevalence of gynecological disorders such as endometriosis and uterine fibroids is significantly fueling the demand for laparoscopic interventions. Laparoscopy is increasingly preferred for the diagnosis and treatment of these conditions due to its ability to offer targeted, minimally invasive management with lower postoperative complications and faster recovery compared to open surgery. According to the World Health Organization (WHO), around 10% or approximately 190 million reproductive-age individuals globally are affected by endometriosis. Similarly, a study published in Springer Nature in May 2023 analyzed global trends in uterine fibroids from 1990 to 2019, revealing a 67% increase in incidence, 79% in prevalence, and 77% in years lived with disability. Age-period-cohort modeling indicated rising burdens, especially in low- and middle-Socio-demographic Index regions, with peak incidence at ages 35-44. This rise in gynecological procedures significantly contributesto the rise in demand for advanced laparoscopic procedures.
Moreover, the trend toward early-stage detection of gynecological conditions, driven by increased awareness and access to gynecological care, has expanded the pool of eligible patients for laparoscopic gynecological procedures. This shift is pushing healthcare facilities to invest in laparoscopic systems and training. Manufacturers of laparoscopic instruments and energy devices are capitalizing on this surge by offering disease-specific toolkits, such as fibroid morcellators and endometriosis resection kits, which are increasing procedural efficiency.
Global Laparoscopic Gynecological Procedures Market Report Segmentation
This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the global laparoscopic gynecological procedures market report based on procedure, end-use, and region:Procedure Outlook (Revenue, USD Million, 2021 - 2033)
- Laparoscopic Hysterectomy
- Laparoscopic Adnexal
- Laparoscopic Endometrial Excision
- Laparoscopic Diagnostic Procedures
- Laparoscopic Myomectomy
- Laparoscopic Colpopexy
End-use Outlook (Revenue, USD Million, 2021 - 2033)
- Hospitals
- Ambulatory Surgery Centers
- Clinics
Regional Outlook (Revenue, USD Million, 2021 - 2033)
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- Japan
- China
- India
- Australia
- Thailand
- South Korea
- Latin America
- Brazil
- Argentina
- Middle East and Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listing for you to stay ahead of the curve
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Laparoscopic Gynecological Procedures Market Variables, Trends & Scope
Chapter 4. Laparoscopic Gynecological Procedures Market: Procedure Estimates & Trend Analysis
Chapter 5. Laparoscopic Gynecological Procedures Market: End Use Estimates & Trend Analysis
Chapter 6. Laparoscopic Gynecological Procedures Market: Regional Estimates & Trend Analysis by Procedure, End Use
Chapter 7. Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
- Medtronic
- Stryker
- Karl Storz SE & CO. Kg
- Johnson and Johnson
- Olympus Corporation
- CONMED Corporation
- B. Braun SE
- CooperCompanies
- Richard Wolf GmbH
- Microline Surgical
- Welfare Medical Ltd.
- Intuitive Surgical
- Shenzhen Mindray Bio Medical Electronics Co., Ltd.
